Related Experiment Video
Updated: Aug 19, 2026

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
Published on: October 2, 2015
[Diagnosis and staging of malignant pleural mesothelioma]
1Ruhrlandklinik Essen, Abteilung Pneumologie, Universitätsklinik, Germany. sebastian.sohrab@ob.kamp.net
Abstract:
Malignant pleural mesothelioma (MPM) is an aggressive solid tumor with rising incidence and mortality. Due to a long latency period after asbestos exposure until tumor manifestation the peak of newly diagnosed MPM cases is to be expected for the year 2017 in Germany. One deciding factor for the poor prognosis with a median survival of 4 - 18 month is a late diagnosis at an advanced stage. Therefore, apart of improved stage related therapeutic options, early diagnostic procedures in suspected MPM play a key role. The diagnosis of MPM is made by the clinician as a synopsis of clinical, imaging and pathological findings. Computed tomography of the thorax and thoracoscopy with biopsy are the most important diagnostic procedures. Staging is recommended to be made as TNM description according to the International Mesothelioma Interest Group (IMIG) to allow a better comparability of various data in MPM.
Insights
Malignant pleural mesothelioma (MPM), a cancer linked to asbestos, often presents late, impacting prognosis. Early diagnosis through imaging and biopsy is crucial for better management of this aggressive tumor.
Area of Science:
- Oncology
- Pulmonology
- Pathology
Context:
- Malignant pleural mesothelioma (MPM) incidence and mortality are rising.
- A long latency period after asbestos exposure leads to late-stage diagnosis.
- Germany anticipated a peak in MPM cases around 2017.
Purpose:
- To emphasize the critical role of early diagnostic procedures in suspected MPM.
- To highlight the importance of accurate staging for data comparability.
- To underscore the need for improved therapeutic options for MPM.
Summary:
- MPM diagnosis relies on a synthesis of clinical, imaging, and pathological findings.
- Thoracic computed tomography and thoracoscopy with biopsy are key diagnostic tools.
- International Mesothelioma Interest Group (IMIG) TNM staging is recommended.
Impact:
- Timely diagnosis significantly influences patient prognosis and survival.
- Standardized staging improves the comparability of clinical data and research.
- Enhanced diagnostic strategies are vital for managing aggressive MPM.
Related Concept Videos
Pleural Disorders: Types and Brief Description
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Endoscopic Studies I: Bronchoscopy and Thoracoscopy
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due to...
Mitral Stenosis II: Clinical features and Diagnostic Tests
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

